Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
3-Methylbenzofuran-2-carboxylic Acid Methyl Ester acts as a reagent in the synthesis and SAR of highly selective MMP-13 Inhibitors, preparation of saframycin analogs for the treatment of cancer.